T43.202 Poisoning by unspecified antidepressants, intentional self-harm

Name of the Condition

• Poisoning by unspecified antidepressants, intentional self-harm

Summary

This condition refers to an intentional self-harm poisoning resulting from the ingestion or exposure to unspecified antidepressant medications. It is identified when a patient presents with symptoms of toxicity following a deliberate act of self-poisoning, typically documented with a clear intent to harm oneself. Unspecified antidepressants indicate the specific drug type is not documented, and the diagnosis relies on clinical presentation and medication history.

Causes

Intentional self-harm poisoning by antidepressants occurs when a patient deliberately takes an overdose of these medications. This may involve consuming more than the prescribed dose or accessing additional supplies. The act is driven by suicidal intent or self-injurious behavior, and the specific antidepressant is not identified in the documentation.

Risk Factors

• History of mental health conditions, such as depression, anxiety, or suicidal ideation.
• Prior episodes of self-harm or suicide attempts.
• Access to antidepressant medications without supervision.
• Lack of social support or coping mechanisms during periods of distress.

Symptoms

• Drowsiness, confusion, or altered mental status.
• Rapid heart rate, low blood pressure, or irregular heartbeat.
• Nausea, vomiting, or abdominal pain.
• Seizures, respiratory depression, or coma in severe cases.

Diagnosis

Diagnosis involves reviewing the patient’s medication history, clinical symptoms, and circumstances of exposure. Toxicology screening may be performed to confirm antidepressant presence, though the specific drug type remains unspecified. Documentation of intent (e.g., suicidal ideation) and clinical findings support the diagnosis.

Treatment Options

Treatment focuses on stabilizing the patient, which may include airway management, intravenous fluids, and activated charcoal to reduce absorption. Antidotes or supportive care (e.g., for seizures or cardiac issues) are administered as needed. Psychiatric evaluation and intervention are critical to address the underlying intent.

Prognosis and Follow-Up

Prognosis depends on the severity of the poisoning and timely intervention. Close monitoring for complications is essential. Follow-up care includes psychiatric support, medication management, and safety planning to reduce future risk of self-harm.

Complications

• Severe respiratory depression or failure.
• Cardiac arrhythmias or cardiac arrest.
• Seizures or neurological damage.
• Long-term psychiatric or cognitive effects.

Lifestyle & Prevention

• Secure storage of medications to limit access.
• Regular mental health check-ins and therapy.
• Education on medication safety and overdose risks.
• Development of crisis management plans with healthcare providers.

When to Seek Professional Help

Seek immediate medical attention if self-harm is suspected or if symptoms of poisoning (e.g., drowsiness, confusion, or respiratory distress) occur. Contact emergency services or a mental health professional for support.

Tips for Medical Coders

Document the intent (intentional self-harm) clearly in the medical record, as this distinguishes the code from accidental or therapeutic exposures. Ensure the unspecified nature of the antidepressant is noted, and verify that the code aligns with the clinical scenario and documentation.